COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,234 Articles (22,733 medRxiv, 8,501 bioRxiv)

Most recent first Previous |  Page 1884: Articles 18831-18840  | Next

Electronic Computer-Based Model of Combined Ventilation Using a New Medical Device
Ramos, M., Orofino, R., Riva, D., Biancolini, M. F., Lugones, I.
10.1101/2021.01.17.21249912 — Posted: 2021-01-20
Physician Perceptions of Catching COVID-19
Doraiswamy, P. M., Chilukuri, M., Ariely, D., Linares, A. R.
10.1101/2021.01.15.20249089 — Posted: 2021-01-20
COVID-19 propagation by diffusion - a two-dimensional approach for Germany
Baerwolff, G. K. F.
10.1101/2021.01.15.21249893 — Posted: 2021-01-20
Estimating the effects of non-pharmaceutical interventions on the number of new infections with COVID-19 during the first epidemic wave
Banholzer, N., van Weenen, E., Lison, A., Cenedese, A., Seeliger, A., Kratzwald, B., Tschernutter, D., Salles, J. P., Bottrighi, P., Lehtinen, S., Feuerriegel, S., Vach, W.
10.1101/2021.01.15.21249884 — Posted: 2021-01-20
Regression Tree Modelling to Predict Total Average Extra Costs in Household Spending During COVID-19 Pandemic
Lotfy, N.
10.1101/2021.01.15.21249732 — Posted: 2021-01-20
COVID-19 Knowledge, Attitudes, and Practices of United Arab Emirates Medical and Health Sciences Students: A Cross Sectional Study
Baniyas, N., Sheek-Hussein, M. M., Al Kaabi, N., Al Shamsi, M., Al Neyadi, M. M., Al Khoori, R., Ajab, S., Abid, M., Grivna, M., Abu Zidan, F. M.
10.1101/2021.01.19.427250 — Posted: 2021-01-19
SARS-CoV-2 infection of circulating immune cells is not responsible for virus dissemination in severe COVID-19 patients
Rosin, N. L., Jaffer, A., Sinha, S., Mulloy, R. P., Robinson, C., Labit, E., Almeida, L. G., Dufour, A., Corcoran, J. A., Yipp, B., Biernaskie, J.
10.1101/2021.01.19.427282 — Posted: 2021-01-19
Sterically-Confined Rearrangements of SARS-CoV-2 Spike Protein Control Cell Invasion
Dodero Rojas, E., Onuchic, J. N., Whitford, P.
10.1101/2021.01.18.427189 — Posted: 2021-01-19
BRD2 inhibition blocks SARS-CoV-2 infection in vitro by reducing transcription of the host cell receptor ACE2
Tian, R., Samelson, A. J., Rezelj, V. V., Chen, M., Ramadoss, G. N., Guo, X., Mac Kain, A., Tran, Q. D., Lim, S. A., Lui, I., Nunez, J., Rockwood, S. J., Liu, N., Carlson-Stevermer, J., Oki, J., Maures, T., Holden, K., Weissman, J. S., Wells, J. A., Conklin, B., Vignuzzi, M., Kampmann, M.
10.1101/2021.01.19.427194 — Posted: 2021-01-19
Azithromycin Plus Zinc Sulfate Rapidly and Synergistically Suppresses IκBα-Mediated In Vitro Human Airway Cell ACE2 Expression for SARS-CoV-2 Entry
Chen, Y.-K., Huang, T.-T., Chang, C.-W., Lee, M.-C., Lin, B.-R., Lu, Y.-P., Hsu, Y.-J., Chuang, C.-Y.
10.1101/2021.01.19.427206 — Posted: 2021-01-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).